Announcements Trials

Browse Landscape

Phase

Status

Completed 11 Withdrawn 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 10 Colonic Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Lung Neoplasms 2 Carcinoma, Renal Cell 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Unresectable Metastatic Colorectal Cancer 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Ras-mutated Metastatic Colorectal Cancer 1 Prostatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Margins of Excision 1 Kidney Neoplasms 1 Histiocytosis 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1

Interventions

Capecitabine 29 Oxaliplatin 28 Fluorouracil 16 Radiotherapy 15 Drug Therapy 11 Leucovorin 10 Bevacizumab 10 Surgical Procedures, Operative 9 Chemoradiotherapy 8 Radiation 7 sintilimab 6 Consolidation Chemotherapy 6 tislelizumab 5 spartalizumab 5 XELOX 5 Specimen Handling 5 Irinotecan 5 Folfox protocol 5 trifluridine tipiracil drug combination 4 Neoadjuvant Therapy 4 Endoscopy 4 Cetuximab 4 Biopsy 4 toripalimab 3 pembrolizumab 3 irinotecan sucrosofate 3 X-Rays 3 Radiotherapy, Intensity-Modulated 3 Proctectomy 3 Mastectomy, Segmental 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Rectal Neoplasms × IFL protocol × Clear all

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡